CORSICO, ANGELO GUIDO
 Distribuzione geografica
Continente #
NA - Nord America 4.406
EU - Europa 3.081
AS - Asia 2.227
SA - Sud America 28
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 9.754
Nazione #
US - Stati Uniti d'America 4.372
CN - Cina 1.938
IE - Irlanda 940
UA - Ucraina 483
IT - Italia 466
FI - Finlandia 381
DE - Germania 312
SG - Singapore 231
SE - Svezia 181
GB - Regno Unito 119
FR - Francia 99
CA - Canada 34
BE - Belgio 33
BR - Brasile 19
IN - India 19
NL - Olanda 13
CZ - Repubblica Ceca 12
JP - Giappone 11
RU - Federazione Russa 11
HK - Hong Kong 9
LT - Lituania 8
MU - Mauritius 6
RO - Romania 5
CL - Cile 4
DK - Danimarca 4
PL - Polonia 4
AU - Australia 3
PH - Filippine 3
VN - Vietnam 3
AR - Argentina 2
AT - Austria 2
ES - Italia 2
EU - Europa 2
GR - Grecia 2
IR - Iran 2
MK - Macedonia 2
MY - Malesia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CO - Colombia 1
EC - Ecuador 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
PE - Perù 1
SA - Arabia Saudita 1
TH - Thailandia 1
TR - Turchia 1
Totale 9.754
Città #
Chandler 951
Dublin 939
Jacksonville 608
Nanjing 559
Boardman 298
Ashburn 296
Nanchang 228
Princeton 186
Lawrence 181
Beijing 180
Wilmington 175
Shenyang 154
Singapore 148
Changsha 145
Ann Arbor 137
Helsinki 136
Jiaxing 118
Hebei 114
Medford 111
Milan 93
Tianjin 88
Hangzhou 82
Shanghai 77
Pavia 68
Woodbridge 66
Dearborn 62
New York 51
Verona 39
Norwalk 35
Brussels 32
Seattle 31
Los Angeles 28
Toronto 28
Falls Church 26
Houston 25
Kunming 24
Rome 23
Fairfield 18
Munich 17
Washington 17
Mulazzano 16
Tappahannock 16
Pune 15
Jinan 14
Piemonte 14
Piscataway 14
Auburn Hills 13
Guangzhou 12
Redwood City 12
Brno 11
Chicago 11
Dallas 11
Des Moines 11
London 11
Tokyo 11
Borås 9
Frankfurt am Main 8
Hong Kong 8
Ningbo 8
Parma 8
Taizhou 8
Zhengzhou 8
Florence 7
Lenola 7
San Francisco 7
Berlin 6
Brescia 6
Lyon 6
Chongqing 5
Falkenstein 5
Fuzhou 5
Hefei 5
Paris 5
Redmond 5
Bologna 4
Chengdu 4
Hårlev 4
Orange 4
Turin 4
Cambridge 3
Changchun 3
Espoo 3
Fort Worth 3
Laives 3
Montesilvano Marina 3
Nuremberg 3
Padova 3
Quanzhou 3
Rockville 3
Santa Clara 3
Shantou 3
Vicenza 3
Wuhan 3
Amsterdam 2
Aversa 2
Bientina 2
Bovezzo 2
Buenos Aires 2
Caserta 2
Colle Di Val D'elsa 2
Totale 6.988
Nome #
Il test da sforzo cardiopolmonare (TCP) nello studio delle malattie respiratorie e in riabilitazione. Parte II. 105
Test di provocazione bronchiale con metacolina (TPBM). Riflessioni sulle linee guida ATS 1999 – confronti con le linee guida ERS 1993. 98
Temporal trend in the prevalence of asthma-like symptoms among young adults of Northern Italy. Results of European Community Respiratory Health Survey (ECRHS) – ITALY 2000 97
Lyosecretome for use in the treatment or prevention of skin aging by inhibiting elastase and tyrosinase activity 97
Lyosecretome for use in the treatment of autoimmune diseases 97
Lyosecretome for use in the treatment of degenerative osteoarticular diseases and/or degenerative intervertebral disc disease. 91
Chronic cough and phlegm in young adults 89
Asthma control in Europe: a real-world evaluation based on an international population-based study 84
Long-term effects of pulmonary andoarterectomy on cardioplmonary function and exercise tolerance 84
Il rapporto VEMS/CVF come cut-off fisso é un parametro accurato e affidabile per la diagnosi funzionale di ostruzione bronchiale nella BPCO: CON | [FEV1/FVC as a fixed cut-off is an accurate and reliable parameter for functional diagnosis of bronchial obstruction in COPD: CON] 80
Aerosol thermal therapy benefit in chronic bronchitis treatment. 79
Linee guida per la misurazione ed interpretazione dei valori di ossigenazione arteriosa. 79
Bronchial responsiveness to ultrasonic fog in occupational asthma due to toluene diisocyanate 79
Mechanisms for isolated volume response to a bronchodilator in patients with COPD 79
Assessment of emphysema in COPD. A functional and radiologic study 78
Asthma in childhood reduces smoking initiation in subsequent teenage among males. 76
Persistent exercise limitation after successful pulmonary endoarterectomy: frequency and determinants 76
Pulmonary endarterectomy: the lancet first, tears for pills. 74
Allergic rhinitis and asthma comorbidity in a survey of young adults in Italy. 74
Long-term outcome after pulmonary endarterectomy. 74
ADRB2 Gly16Arg polymorphism, asthma control and lung function decline. 73
Lyosecretome for use in the treatment of alpha-1-antitrypsin deficiency associated diseases 72
Lung function in survivors of childhood acute lymphoblastic leukemia 71
Patients' interest in educational programmes on asthma. 71
Late pulmonary sequelae after childhood bone marrow transplantation 71
Human health and air conditioning systems. 69
Exacerbations as a starting point of pro-active chronic obstructive pulmonary disease management. 69
Assessment and management of pulmonary alveolar proteinosis in a reference center. 68
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 68
Il test da sforzo cardiopolmonare (TCP) nello studio delle malattie respiratorie e in riabilitazione. Parte I. 67
Effects of inhaled steroids on methacholine-induced bronchoconstriction and gas trapping in mild asthma. 67
Chronic productive cough in young adults is very often due to chronic rhino-sinusitis 67
"Nonobstructive" emphysema of the lung 66
Occupational asthma caused by milk proteins: report on a case. 66
Quality-of-life and asthma-severity in general population asthmatics: results of the ECRHS II study 66
Long-term outcomes of pulmonary endarterectomy (PEA) for chronic thromboembolic pulmonary hypertension (CTEPH) 66
Incidence of COPD in a Cohort of Young Adults According to the Presence of Chronic Cough and Phlegm. 66
The role of climate on the geographic variability of asthma, allergic rhinitis and respiratory symptoms: results from the Italian study of asthma in young adults. 65
Atmosphere pollutants 64
Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults 64
Changes in the use of anti-asthmatic medication in an international cohort. 64
Are the asthma guideline goals achieved in daily practice? A population-based study on treatment adequacy and the control of asthma 64
Freeze-dried MSC-secretome contains active alpha-1-antitrypsin for treatment of deficiency pulmonary diseases 63
The Rapid FEV(1) Decline in Chronic Obstructive Pulmonary Disease Is Associated with Predominant Emphysema: A Longitudinal Study. 62
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 61
Lung cancer resection: the prediction of postsurgical outcomes should include long-term functional results. 61
Prevalence of allergic rhinitis in young adults in Italy 61
Valutazione preoperatoria in chirurgia toracica. 61
Changes in IgE sensitization and total IgE levels over 20 years of follow-up 61
Longterm hemodynamic and functional results after pulmonary endarterectomy 61
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 61
An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. 61
RESPIRATORY SYMPTOMS AND PULMONARY FUNCTION IN THE POPULATION OF PARONA (PV) ACCORDING TO TOBACCO EXPOSURE 60
Long-term clinical and cardiopulmonary effects of pulmonary endarteriectomy (PEA) 60
Asthma Severity According to Global Initiative for Asthma and Its Determinants:An International Study. 60
Asthmatics and ex-smokers respond early, heavy smokers respond late to mailed surveys in Italy. 60
Inadequate antiasthma drug use in the north of Italy. 59
Allergen-specific immunoglobulin E and allergic rhinitis severity 59
SORVEGLIANZA DELLE MALATTIE BRONCOPOLMONARI CRONICO-OSTRUTTIVE NELLA POPOLAZIONE DI ROVESCALA (PAVIA) IN RELAZIONE ALL’ ESPOSIZIONE AL FUMO DI TABACCO 59
The socio-economic burden of asthma is substantial in Europe. 58
COPD classification methods and informativeness on mortality: contrasting evidences. 58
Pulmonary involvement in patients with Marfan Syndrome. 58
Bioequivalence of inhaled formoterol fumarate assessed from pharmacodynamic, safety and urinary pharmacokinetic data. 57
International variations in asthma treatment compliance: the results of the European Community Respiratory Health Survey (ECRHS). 57
Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. 57
Impact of asthma and comorbid allergic rhinitis on quality of life and control in patients of Italian general practitioners. 57
Freeze-dried MSC-secretome for use in the treatment of alpha-1-antitrypsin deficiency pulmonary diseases 57
Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study 57
Mid term effects of pulmonary thromboendarterectomy on clinical and cardiopulmonary function status 56
Prediction of FEV1 reductions in patients undergoing pulmonary resection. 56
Mesenchymal Extracellular Vesicles as Alpha-1-antitrypsin physiological delivery systems for lung regeneration 56
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 56
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome 56
Effects of exercise and beta 2-agonists on lung function in chronic obstructive pulmonary disease 55
Epidemiologia e fattori di rischio. 55
Paediatric Oncology and Bone Marrow Transplantation. 55
Followup a lungo termine di pazienti affetti da ieprtensione polmonare cronica tromboembolica sottoposti ad endoarteriectomia polmonare 55
Time trends in smoking habits among Italian young adults 55
MSC extracellular vesicles for treatment of alpha-1-antitrypsin deficiency pulmonary diseases 55
COPD screening in high-risk groups 54
Peak expiratory flow monitoring and airway response to specific bronchial provocation tests in asthmatics 54
The course of asthma during pregnancy in a recent, multicase-control study on respiratory health 54
Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration 54
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 54
Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies 54
Position Paper sulla sicurezza di impiego degli steroidi inalatori nell’asma. 53
Inhaled steroids are associated with reduced lung function decline in subjects with asthma with elevated total IgE. 53
Principi di terapia farmacologica. 53
Body mass index, weight gain, and other determinants of lung function decline in adult asthma. 53
The possible influence of the environment on respiratory allergy: a survey on immigrants to Italy. 53
The Impact of Diagnosed and Undiagnosed Current Asthma in the General Adult Population 53
Socioeconomic inequalities in smoking habits are still increasing in Italy. 53
Is the prevalence of adult asthma and allergic rhinitis still increasing? Results of an Italian study 53
The prevalence of asthma-like symptoms has not increased among adults of Northern Italy, during the Nineties 52
The impact of cigarette smoking on asthma: a population-based international cohort study. 52
Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. 52
Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital 52
Pulmonary function in patients with systemic sclerosis 51
Etiopathogenetic role of pollens. 51
Prognostic factors of asthma severity : A 9-year international prospective cohort study 51
Totale 6.439
Categoria #
all - tutte 45.613
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.613


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020547 0 0 0 0 0 113 31 137 14 183 64 5
2020/20211.025 126 89 29 97 21 127 14 184 32 149 129 28
2021/2022796 10 19 23 7 26 33 34 41 55 23 137 388
2022/20232.791 341 144 27 278 230 284 7 180 1.151 21 82 46
2023/20241.079 118 203 47 65 118 238 51 85 10 48 30 66
2024/2025942 70 223 102 149 94 304 0 0 0 0 0 0
Totale 9.988